A Multicenter, Single-Blind Randomized, Controlled Study of a Volumizing Hyaluronic Acid Filler for Midface Volume Deficit: Patient-Reported Outcomes at 2 Years.

ABSTRACT:

Background

Juvéderm Voluma XC is a volumizing hyaluronic acid filler used for correction of age-related midface volume deficit (MVD).

Objectives

The effectiveness of Juvéderm Voluma XC was examined from the patient perspective.

Methods

Patients with moderate to severe age-related MVD (N = 235) received Juvéderm Voluma XC. At quarterly follow-up visits for 2 years, patients rated treatment outcomes on the Global Aesthetic Improvement Scale (GAIS), overall satisfaction with facial appearance, satisfaction with midfacial regions, achievement of treatment goal, Look and Feel of the Midface (LAFM), and Self-Perception of Age (SPA). Patients recorded treatment-site responses in 30-day diaries.

Results

At 6 months and 2 years after treatment, 92.8% and 79.0% of patien

SUBMITTER: Few J 

PROVIDER: S-EPMC4482214 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature